COVID-19 Analysis in India presentation.pptx

Nov 25, 2024Download as PPTX, PDF0 likes38 views

chalamalauday

This presentation provides an in depth analysis of covid 19 cases.

COVID-19 Analysis in India
ANALYZING TRENDS, VACCINATION COVERAGE, AND
RELATIONSHIPS BETWEEN CASES AND VACCINATION EFFORTS.
This presentation provides an in-depth analysis of COVID-19 cases,
vaccination coverage, and testing trends across India. By exploring
datasets that track daily case updates, state wise vaccination progress,
and testing efforts, we aim to uncover insights that can guide decisions in
managing the pandemic.

Data Sources
COVID-19 India Dataset: Daily updates on confirmed cases, recoveries, and deaths across
Indian states.
COVID-19 Vaccine Data: Progress on vaccinations in different states, including gender
distribution.
State wise Testing Data: Statistics on COVID-19 testing, number of tests conducted by state

COVID-19 Cases Over Time
A time-series visualization showing the trend of confirmed, active, cured, and death cases.
Key Insight: The confirmed and active cases saw significant increases over time, but recovered and death cases also
followed upward trends.

State wise COVID-19 Death Rate
The death rate was calculated as the number of deaths divided by confirmed cases.
Key Insight: Certain states had significantly higher death rates compared to others.

Top 10 States with Highest Cured Cases
The top 10 states with the highest number of cured cases were analyzed.
Key Insight: These states had a higher recovery rate, helping in managing the
pandemic effectively.

Vaccination Coverage by Gender
A breakdown of the vaccination distribution by gender (male, female, transgender).
Key Insight: The majority of the vaccinations were administered to males, followed by
females and a small portion to transgender individuals.

Vaccination Coverage in Different States
Total number of individuals vaccinated across different states.
Key Insight: Some states achieved much higher coverage, playing a key role in
controlling the spread of the virus.

Correlation between COVID-19 Cases and Vaccinations
An analysis of the relationship between the total number of confirmed cases and vaccine doses
administered.
Key Insight: There was a correlation between higher vaccination coverage and a reduction in
COVID-19 cases.

Summary of Findings
Trends show a rapid increase in cases followed by recovery spikes.
Vaccination efforts are crucial in managing case numbers.
High variation in death rates and vaccination coverage across states.
Effective recovery strategies in some states.
Strong correlation between vaccination and reduced case numbers.

Running head: UNIT 8 PROJECT 1 UNIT 8 PROJECT 2 Unit 8 Project Name Community Health Assessment Affiliated University April 02, 2015 Abstract This project is designed to give a bigger picture of the information so far covered in this course unit. It will provide information from project four which was about social behavior theories and its roots and unit six that concerned about Influenza vaccination in senior citizens 65 and over. It will also give some information from project two which was about the role of assessment in public health. Information about child obesity as a health problem in my community will be provided, and a detailed description of how data will be provided for this health problem assessment. A completed health assessment information using a U.S Census on my community and the evaluation of this information, and the information about who may be affected by this child obesity health evaluation and a plan of action, conclusion and a reference page where information was gathered. Unit 8 Project U.S Census data on my County in the State of Maryland Montgomery County is where I live, located in the state of Maryland. Its population as of 2013 was estimated to be 1,016,677 according to (United States Census Bureau), with a racial breakdown of 62.6% white alone, 18.6% Black and African American alone,0.7% American Indian and Alaskan Natives alone, Asians 14.9%,Native Hawaiian and pacific Islanders 0.1%,Two or more races 3.1%,Hispanic and Latino 18.3%.Those who are not Latinos or Hispanic comprise of 47.0% .Female persons comprise of 51.8% and no information was provided about male. Senior citizens sixty five years and over take up 13.3% .Information for people who are disabled was not provided where as children under five years take up a 6.5% and those under 18 years comprised of 23.6%. (United States Census Bureau) Influenza Vaccination Health Assessment from Unit 6 Influenza is a deadly virus that attacks the nose, throat and lungs and it can be spread from one person to another if a sick person sneezes or coughs without covering their mouth and the other person inhales it. In United States alone, Influenza is estimated to be responsible for 36,000 deaths, and 110,000 to 200,000 hospitalizations ("Influenza vaccination," 2003). It is a virus that is prevented mainly through immunization. The world at large and the U.S government in particular, has tried their level best to conduct public health campaigns that encourage influenza vaccination but despite all the effort, a number of people do not turn up due to varied reasons. In such helpless situations an assessment can be carried out to help health care advocates find out factors affecting vaccine commitment. A good example of this is from county of Los Angeles where immunization was carried out to people who are 65 and over noted to be one of those at high risk but to their surprise a few categories of people didn’t turn up for immunization. Results from Los Angeles Cou ...

6. Data and Additional Measures of Disease Occurrence 2.pptxMuhammadKhalil858111

��

applications of epidemiologySagar Dalal

��

Epidemiology has several common practical applications. It is used to investigate infectious diseases through routine surveillance by health departments. Epidemiologists in hospitals explore causes of hospital-acquired infections. It also evaluates the impact of public health policies on trends like smoking rates and obesity. Overall, epidemiology provides data to understand community health issues and disease risks, identify disease syndromes, uncover disease causes, and evaluate treatments and interventions.

New Study Identifies Population-Wide Immune Setpoint for COVID-19 Antibodies.pdfThe Lifesciences Magazine

��

GROUP NUMBER 3,EPIDEMIOLOGY.ppt researchpsourcedevie

��

Global HIV cohort studies among IDU and future vaccine trialsThira Woratanarat

��

The author reviewed data on the global HIV epidemic among injecting drug users (IDUs) and identified potential cohorts of IDUs that could participate in future HIV vaccine trials. High HIV prevalence rates were observed among IDUs in many countries in Asia, Eastern Europe, Latin America, and parts of Africa and North America. Several cohort studies also showed high HIV incidence rates among IDUs in China, Thailand, Canada, and Spain. These findings emphasize the seriousness of the IDU epidemic globally and the potential for IDU cohorts to participate in HIV vaccine trials due to demonstrated high participation and retention rates in past studies.

Increases in covid‑19 are unrelated to levels of vaccination across....Laurent Sailly

��

HIV Epidemiology in the Prairiesgriehl

��

The document discusses HIV epidemiology in Saskatchewan, highlighting that the province has seen a rapid increase in new HIV cases and now has the highest rates in Canada. It summarizes Saskatchewan's 2010-2013 HIV Strategy, which aims to reduce new infections and improve quality of life for those living with HIV through improved surveillance, clinical management, prevention, and harm reduction programs. The strategy goals include earlier detection of cases, decreasing new infections and sexually transmitted infections, and increasing access to testing, care, and prevention services.

e632 www.thelancet.comhiv Vol 6 September 2019ViewpoiAlyciaGold776

��

e632 www.thelancet.com/hiv Vol 6 September 2019 Viewpoint The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment Stefan Baral, Amrita Rao, Patrick Sullivan, Nancy Phaswana-Mafuya, Daouda Diouf, Greg Millett, Helgar Musyoki, Elvin Geng, Sharmistha Mishra In 2019, the HIV pandemic is growing and soon over 40 million people will be living with HIV. Effective population- based approaches to decrease HIV incidence are as relevant as ever given modest reductions observed over the past decade. Treatment as prevention is often heralded as the path to improve HIV outcomes and to reduce HIV incidence. Although treatment of an individual does eliminate onward transmission to serodifferent partners (unde tectable=untransmittable or U=U), population-level observational and experimental data have not shown a similar effect with scale-up of treatment on reducing HIV incidence. This disconnect might be the result of little attention given to heterogeneities of HIV acquisition and transmission risks that exist in people at risk for and living with HIV, even in the most broadly generalised epidemics. Available data suggest that HIV treatment is treatment, HIV prevention is prevention, and specificity of HIV treatment approaches towards people at highest risk of onward transmission drives the intersection between the two. All people living with HIV deserve HIV treatment, but both more accurately estimating and optimising the potential HIV prevention effects of universal treatment approaches necessitates understanding who is being supported with treatment rather than a focus on treatment targets such as 90-90-90 or 95-95-95. Introduction In 2019, we are at a pivotal time in the global HIV response in that many people believe that the HIV pandemic is over given the advances in HIV treatment.1 Yet the HIV pandemic continues to grow as defined by numbers of people living with HIV. Specifically, given the encouraging decreases in overall mortality among people living with HIV, in the context of universal treat ment as prevention, approximately 930 000 more people annually (1·7 million new infections minus 770 000 deaths of people living with HIV) require anti retroviral therapy (ART) and many more would need to change ART regimens. At the current rate of new infections, over 40 million people will be living with HIV by 2025.2 The global optimism about the HIV pandemic has not been matched by decreases in new HIV infections. New infections have declined by less than 2% per year since 2005, which means that between 1·8 and 2·5 million people acquired HIV in 2017.2,3 To date, just over 60% of the 37·9 million people living with HIV are on ART; of those 37·9 million, just over half (20·1 million) are estimated to have achieved viral sup pression.2 Taken together, these data suggest that an estimated 18 million people living with HIV require ART or improved ART regimens giv ...

Vaccination2014 150420100600-conversion-gate02Marly0710

��

The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while JNC 8 included treatment algorithms and differences from JNC 7.

Vaccine TruthJohn Bergman

��

The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while the JNC 8 guidelines from 2013 include treatment algorithms and comparisons to JNC 7.

HSA 535EXceptional Education/snaptutorial.COMMcdonaldRyan15

��

This document contains a final exam for HSA 535 that covers topics in epidemiology, including descriptive epidemiology, measures of disease frequency and association, study designs, screening and prevention. It includes 30 multiple choice questions testing knowledge of concepts like rates, cohorts, screening test validation, chronic disease risk factors and occupational health studies. It also provides short discussions on applying epidemiology principles to address issues like type 2 diabetes and cancer screening programs. The exam evaluates understanding of key epidemiology topics and how to apply them to analyze health problems and propose evidence-based solutions.

NUR 440 Evidence TableStudy CitationDesignMethodSample.docxvannagoforth

��

NUR 440 Evidence Table Study Citation Design Method Sample Data Collection Data Analysis Validity Reliability Magill, S. S., O’Leary, E., Janelle, S. J., Thompson, D. L., Dumyati, G., Nadle, J., & Ray, S. M. (2018). Changes in prevalence of health care–associated infections in US Hospitals.��New England Journal of Medicine,��379(18), 1732-1744. Longitudinal and multivariable log-binomial regression modeling At Emerging Infections Program sites in 10 states, we recruited up to 25 hospitals in each site area, prioritizing hospitals that had participated in the 2011 survey. Random samples of patients in acute care locations were selected from hospitals’ morning censuses on the survey date with the use of the method that had been used in the 2011 survey Trained staff of the Emerging Infections Program sites reviewed medical records on the survey date or retrospectively to collect basic demographic and clinical data. In 2015, a total of 12,299 patients in 199 hospitals were surveyed, as compared with 11,282 patients in 183 hospitals in 2011. Pneumonia, gastrointestinal infections and surgical-site infections were the most common health care–associated infections. The CDC determined the survey to be a non-research activity. Point-prevalence surveys of health care–associated infections in health care settings complement location- or infection-specific National Healthcare Safety Network data. Zuarez-Easton, S., Zafran, N., Garmi, G., & Salim, R. (2017). Postcesarean wound infection: prevalence, impact, prevention, and management challenges.��International journal of women's health,��9, 81. Randomized trials, cohort, case–control, review, and meta-analysis were eligible. Several electronic databases were searched from inception through June 2016: MEDLINE, PubMed, Ovid, and the Cochrane Library. 100,000 maternities compared to the period between 2003 and 2005 Data was collected through maternal comorbidities, appropriate antibiotic prophylaxis, and evidence-based surgical techniques practices. Cesarean delivery is one of the most frequent surgical interventions performed worldwide and accounts for up to 60% of deliveries in a number of countries Two authors (SZE and RS) selected articles first through focused review of abstracts. Eligible studies underwent full-text review. The research Reviewed maternal death in the UK over a period of 3 years (2006–2008). Chu, K., Maine, R., & Trelles, M. (2015). Cesarean section surgical site infections in sub-Saharan Africa: a multi-country study from Medecins Sans Frontieres.��World journal of surgery,��39(2), 350-355. Logistic regression was used to model determinants of SSI. This study included data from four emergency obstetric programs supported by Medecins sans Frontieres, from Burundi, the Democratic Republic of Congo (DRC), and Sierra Leone. 1,276 women underwent CS. Data were prospectively collected using a standardized paper form and then entered into an electronic database. Baseline characteristics w ...

RESEARCH ARTICLEWill Combined Prevention Eliminate Racia.docxronak56

��

RESEARCH ARTICLE Will "Combined Prevention" Eliminate Racial/ Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City? Don Des Jarlais1*, Kamyar Arasteh1, Courtney McKnight1, Jonathan Feelemyer1, Holly Hagan2, Hannah Cooper3, Aimee Campbell4, Susan Tross4, David Perlman1 1 The Baron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, New York, New York, United States of America, 2 College of Nursing, New York University, New York, New York, United States of America, 3 Rollins School of Public Health at Emory University, Atlanta, Georgia, United States of America, 4 Department of Psychiatry, Columbia University, New York, New York, United States of America * [email��protected] Abstract It has not been determined whether implementation of combined prevention programming for persons who inject drugs reduce racial/ethnic disparities in HIV infection. We examine racial/ethnic disparities in New York City among persons who inject drugs after implementation of the New York City Condom Social Marketing Program in 2007. Quantitative inter- views and HIV testing were conducted among persons who inject drugs entering Mount Sinai Beth Israel drug treatment (2007–2014). 703 persons who inject drugs who began injecting after implementation of large-scale syringe exchange were included in the analyses. Factors independently associated with being HIV seropositive were identified and a pub- lished model was used to estimate HIV infections due to sexual transmission. Overall HIV prevalence was 4%; Whites 1%, African-Americans 17%, and Hispanics 4%. Adjusted odds ratios were 21.0 (95% CI 5.7, 77.5) for African-Americans to Whites and 4.5 (95% CI 1.3, 16.3) for Hispanics to Whites. There was an overall significant trend towards reduced HIV prevalence over time (adjusted odd ratio = 0.7 per year, 95% confidence interval (0.6– 0.8). An estimated 75% or more of the HIV infections were due to sexual transmission. Ra- cial/ethnic disparities among persons who inject drugs were not significantly different from previous disparities. Reducing these persistent disparities may require new interventions (treatment as prevention, pre-exposure prophylaxis) for all racial/ethnic groups. Introduction Significant racial/ethnic disparities in HIV infection among persons who inject drugs (PWID) have been observed in many countries, with ethnic minority group members [1] and females [2] typically having higher HIV prevalence. There are effective interventions to reduce HIV transmission among PWID, and the logic of “combined” prevention programming is that PLOS ONE | DOI:10.1371/journal.pone.0126180 May 12, 2015 1 / 11 OPEN ACCESS Citation: Des Jarlais D, Arasteh K, McKnight C, Feelemyer J, Hagan H, Cooper H, et al. (2015) Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City? PLoS ONE 10(5): e0126180. doi:10.1371/journal.pone.0126 ...

Medical.editedGodfrey Arap Kangogo

��

This document reviews literature on anaesthetic considerations for HIV-positive parturients. Several studies found that regional anaesthesia can be safely administered and does not negatively impact immune function or disease progression in asymptomatic HIV-positive women. While some early concerns existed around potential neurological complications, more recent research has found no increased risk. The choice of anaesthesia should be based on standard obstetric factors, with regional anaesthesia being a good option for caesarean delivery when there are no contraindications. Overall, the literature indicates that with proper clinical management including antiretroviral therapy, both general and regional anaesthesia can be used safely in HIV-positive parturients.

Cancer Biomarkers Research, HPV and Cancer, HPV VaccineJames Lyons-Weiler

��

The document discusses HPV (human papillomavirus) and cancer biomarkers. It notes that HPV vaccines target certain high-risk HPV types linked to cancers like cervical cancer. Some studies have found evidence of "type replacement" where non-vaccine HPV types increase in prevalence after vaccination, potentially limiting vaccine effectiveness. However, other studies have not found clear evidence of type replacement or have dismissed observed increases in non-vaccine types. There is ongoing debate about the ability of HPV vaccines to prevent cancer and their long-term safety profile based on limitations in clinical trials.

Meghaan Walsh HJS Poster[1]Mary Beth Levin

��

Syringe exchange programs (SEPs) have been shown to be a cost-effective intervention for preventing HIV among injection drug users (IDUs). SEPs are associated with an 80% reduction in HIV incidence among IDUs over the last 20 years. While HIV rates have decreased among most groups, IDUs have seen one of the largest improvements due in large part to SEPs increasing access to sterile syringes. However, SEPs remain controversial in the US despite evidence that they are cost-effective and reduce HIV transmission by providing sterile injection equipment and linking IDUs to healthcare. Further advocacy is needed to restore federal funding for expanding SEPs.

A basic understanding of HIV surveillanceDr.RAJEEV KASHYAP

��

HIV surveillance involves systematically collecting and analyzing HIV/AIDS data to guide prevention and treatment programs. Key aspects of HIV surveillance include monitoring prevalence, incidence, opportunistic infections, and antiretroviral drug resistance. Accurate case definitions and timely reporting are important for effective surveillance. The goals of HIV surveillance are to detect trends in the epidemic, identify at-risk groups, evaluate prevention programs, and inform research and policy.

Lin Final Version - FinalDeborah Lin, M.A.

��

This document analyzes racial disparities in flu vaccination rates in the United States using data from the 2010 National Health Interview Survey. It finds that minorities, especially Black individuals, have significantly lower flu vaccination rates than whites, likely due to barriers to healthcare access. Married individuals and those who are employed have higher vaccination rates than unmarried or unemployed individuals. The document controls for variables like age, sex, and employment status to better understand the independent effect of race and marital status on vaccination rates.

Multiple health problems in elderly peoplepage 950Ex.docxgilpinleeanna

��

Multiple health problems in elderly people page 950 Excessive drinking in young women page 952 Adverse drug reactions in elderly people page 956 Palliative care beyond cancer page 958 Drug resistant infections in poor countries page 948 Management of chronic pain page 954 M A K IN G A D IF FE R E N C E 945BMJ | 26 APRIL 2008 | VOLUME 336 BMJ | Making a difference | 26 april 2008 | VoluMe 336 947 Running the gauntlet to improve patient care This supplement is the result of a gauntlet thrown down, and picked up, during a dinner in London just over a year ago. The gauntlet thrower was Don Berwick, president of the Institute for Healthcare Improvement in Boston. What, he asked, was the BMJ Publishing Group really for? What were we trying to achieve? In reply, I and our chief executive, Stella Dutton, were quick to quote the BMJ’s mission, which ends with the crucial words “to improve outcomes for patients.” Fine, said Don, but how about being more specific: which outcomes, what patients, by how much? We took his suggestion seriously. Why not target a few important healthcare problems, taking a quality improvement approach and focusing on the evidence on how to make a difference in these areas? But how to choose which issues to tackle among the many millions of pressing healthcare challenges facing the world? We turned in the first instance to BMJ readers. In May 2007 we asked you to tell us what information was most needed to improve the quality of care of patients in clinical practice. From your many rapid responses we harvested more than 200 ideas. After categorising these and matching them against the priorities of national and international bodies, we created a shortlist of 12. With the help of an expert panel (see http://makingadifference.bmj.com) we cut these down to six. Inevitably the choice of topics is subjective rather than scientific, but the six we have ended up with are interesting. Several turn the spotlight on areas that are less than glamorous and are perhaps all too often passed over, even as their impact on individual lives and society increases. Two topics deal with problems of old age: multiple illness and adverse drug reactions. Two deal with palliation: of chronic pain and in dying from non-malignant disease. The remaining topics deal with two very different but serious and growing public health challenges: drug resistant infections in the developing world and excessive drinking in young women. You will no doubt find important gaps in what we have chosen. But if this initiative proves useful we can expand it further. On each of the six topics we’ve invited leading commentators to write the pairs of articles that make up this supplement. One article in each pair aims to describe the importance of the problem in terms of its health and societal impact. The other looks at the available evidence on quality improvement initiat ...

Imperial college-covid19-npi-modelling-16-03-2020Mumbaikar Le

��

This document summarizes the results of epidemiological modelling to assess the potential impact of non-pharmaceutical interventions (NPIs) aimed at reducing COVID-19 transmission in the UK and US. It finds that while mitigation strategies could reduce healthcare demand and deaths, hundreds of thousands may still die and healthcare systems would be overwhelmed. Suppression, including social distancing and case isolation, is the preferred option but would need to be maintained until a vaccine is available, around 18 months. Intermittent distancing may allow temporary relaxation but cases would likely rebound without continuous measures. Experience in China and South Korea shows suppression is possible short-term, but long-term feasibility and economic costs require further analysis.

Epidemiological indices afkFarisAhamed2

��

PRINCIPLESOFEPIDEMIOLOGY.pptx Epidemiology foe COsDadaRobert

��

Imperial college covid19 europe estimates and npi impactValentina Corona

��

The document summarizes estimates from a model analyzing COVID-19 mortality data from 11 European countries. Key findings include: - Millions of infections have likely occurred, far more than the number detected. Italy may have had 5.9 million infections (9.8% of population) as of March 28th. - Non-pharmaceutical interventions have likely reduced the reproduction number (Rt) substantially, though estimates vary by country. On average, interventions represent a 64% reduction from initial Rt of around 3.87. - Interventions may have averted 59,000 deaths by March 31st across the 11 countries. More data is needed to determine if Rt has been driven below 1 in

InfluenzaLuis Rangel

��

This document summarizes key information about influenza, including its prevention, diagnosis, treatment, and practice improvement. It notes that influenza is an acute viral respiratory disease that causes millions of medical visits and thousands of deaths annually in the US. Elderly persons have the highest risk of hospitalization and death. The primary prevention method is annual vaccination, with early antiviral treatment providing the greatest clinical benefit for those infected. High-risk groups who should receive vaccination include young children, elderly adults, pregnant women, and those with certain chronic medical conditions. Vaccine effectiveness varies depending on antigenic matching between vaccine and circulating virus strains but is moderately effective at preventing influenza infections.

Vaccine delivery with speed, scale and equityKelley Hodge

��

The value of real-world evidence for clinicians and clinical researchers in t...Arete-Zoe, LLC

��

In the midst of a rapidly spreading global pandemic, real-world evidence can offer invaluable insight into the most promising treatments, risk factors, and not only predict but suggest how to improve outcomes. Despite overwhelming news coverage, significant knowledge gaps regarding COVID-19 persist. The current uncertainties regarding incidence and the case fatality rate can only be addressed by widespread testing. But the paucity of testing, and diversity of approaches implemented in different countries, particularly among the general asymptomatic public, perpetuates a lack of understanding about spread and infectivity. The essential indicators that would describe the pandemic more accurately can be obtained using real-world data (RWD). To that purpose, we designed a data collection tool to collect data from hospitals that treat COVID-19 patients. The captured data will enhance our understanding of the COVID-19 pandemic, identify risk factors relevant for triage, relate to other similar seasonal infections and gain insight into the safety and efficacy of experimental and off-label therapies. Knowledge derived from a focused data collection effort will enable clinicians to adjust rapidly clinical protocols and discontinue interventions that turn out to be ineffective or harmful. By deploying our elegantly designed survey to capture routine clinical indicators, we avoid placing an additional burden on practitioners. Systematically generating real-world evidence can decrease the time to insight compared to randomized clinical trials, improving the odds for patients in rapidly changing conditions.

REvised Infectious diseae papergrewals123

��

Infectious diseases pose a major risk to public health in Canada. There are several contributing factors, including rising antimicrobial resistance due to overprescription of antibiotics, increased risk of vector-borne and waterborne diseases due to climate change, and higher rates of sexually transmitted and healthcare-associated infections. Better surveillance systems, public health initiatives, and prevention programs are needed to address this growing threat.

exampleexampleexampleexampleexampleexampleexampleexamplelembiczkat

��

CloudMonitor - Architecture Audit Review February 2025.pdfRodney Joyce

��

CloudMonitor FinOps is now a Microsoft Certified solution in the Azure Marketplace. This little badge means that we passed a 3rd-party Technical Audit as well as met various sales KPIs and milestones over the last 12 months. We used our existing Architecture docs for CISOs and Cloud Architects to craft an Audit Response - I've shared it below to help others obtain their cert. Interestingly, 90% of our customers are in the USA, with very few in Australia. This is odd as the first thing I hear in every meetup and conference, from partners, customers and Microsoft, is that they want to optimise their cloud spend! But very few Australian companies are using the FinOps Framework to lower Azure costs.

COVID-19 Analysis in India presentation.pptx

1. COVID-19 Analysis in India ANALYZING TRENDS, VACCINATION COVERAGE, AND RELATIONSHIPS BETWEEN CASES AND VACCINATION EFFORTS. This presentation provides an in-depth analysis of COVID-19 cases, vaccination coverage, and testing trends across India. By exploring datasets that track daily case updates, state wise vaccination progress, and testing efforts, we aim to uncover insights that can guide decisions in managing the pandemic.

2. Data Sources COVID-19 India Dataset: Daily updates on confirmed cases, recoveries, and deaths across Indian states. COVID-19 Vaccine Data: Progress on vaccinations in different states, including gender distribution. State wise Testing Data: Statistics on COVID-19 testing, number of tests conducted by state

3. COVID-19 Cases Over Time A time-series visualization showing the trend of confirmed, active, cured, and death cases. Key Insight: The confirmed and active cases saw significant increases over time, but recovered and death cases also followed upward trends.

4. State wise COVID-19 Death Rate The death rate was calculated as the number of deaths divided by confirmed cases. Key Insight: Certain states had significantly higher death rates compared to others.

5. Top 10 States with Highest Cured Cases The top 10 states with the highest number of cured cases were analyzed. Key Insight: These states had a higher recovery rate, helping in managing the pandemic effectively.

6. Vaccination Coverage by Gender A breakdown of the vaccination distribution by gender (male, female, transgender). Key Insight: The majority of the vaccinations were administered to males, followed by females and a small portion to transgender individuals.

7. Vaccination Coverage in Different States Total number of individuals vaccinated across different states. Key Insight: Some states achieved much higher coverage, playing a key role in controlling the spread of the virus.

8. Correlation between COVID-19 Cases and Vaccinations An analysis of the relationship between the total number of confirmed cases and vaccine doses administered. Key Insight: There was a correlation between higher vaccination coverage and a reduction in COVID-19 cases.

9. Summary of Findings Trends show a rapid increase in cases followed by recovery spikes. Vaccination efforts are crucial in managing case numbers. High variation in death rates and vaccination coverage across states. Effective recovery strategies in some states. Strong correlation between vaccination and reduced case numbers.

�ݺ�ߣ

COVID-19 Analysis in India presentation.pptx

Recommended

More Related Content

Similar to COVID-19 Analysis in India presentation.pptx (20)

Recently uploaded (20)

COVID-19 Analysis in India presentation.pptx